Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American Society of Nephrology : JASN"
DOI: 10.1681/asn.2018010009
Abstract: Background Everolimus permits reduced calcineurin inhibitor (CNI) exposure, but the efficacy and safety outcomes of this treatment after kidney transplant require confirmation.Methods In a multicenter noninferiority trial, we randomized 2037 de novo kidney transplant recipients… read more here.
Keywords: everolimus; calcineurin inhibitor; exposure; everolimus reduced ... See more keywords